A Study to Evaluate SIMPONI (Golimumab) Therapy in Children, Adolescents and Young Adults With Pre-Symptomatic Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Golimumab
Related studies linked through entity extraction aliases.
Efficacy of Golimumab in Early Axial Spondyloarthritis in Relation to Gut Inflammation
- Status
- COMPLETED
- Phase
- PHASE3
Golimumab (MK-8259 / SCH900259) Treatment Withdrawal in Participants With Non-radiographic Axial Spondyloarthritis (GO-BACK) (MK-8259-038)
- Status
- COMPLETED
- Phase
- PHASE4
Study of the Golimumab Exposure-Response Relationship Using Serum Trough Levels
- Status
- COMPLETED
- Phase
- PHASE4
Rheumatoid Arthritis Treatment After First Anti-TNF INvestiGation
- Status
- TERMINATED
- Phase
- PHASE4
Golimumab Effect in the Modulation of Gut Microbiota in Ulcerative Colitis
- Status
- COMPLETED
- Phase
- N/A
RABIOPRED - a Validation Study of Theranostic Test to PREDict Treatment Response of Anti-TNFα BIologicals in Rheumatoid Arthritis
- Status
- TERMINATED
- Phase
- N/A
A Study of SIMPONI® to Arrest Beta-cell Loss in Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE2
Thermography in Assessing Treatment Response to Golimumab in Psoriatic Arthritis
- Status
- TERMINATED
- Phase
- NA
NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of Structural Damage in Ankylosing Spondylitis
- Status
- COMPLETED
- Phase
- PHASE4
Intensive Treatment to Reach the Target With Golimumab in ulcErative coliTis - In-TARGET
- Status
- COMPLETED
- Phase
- PHASE4
Registry for Analysis of Compliance in Colombian Participants With Rheumatoid Arthritis Exposed to Golimumab
- Status
- TERMINATED
- Phase
- N/A
Golimumab in Steroid-dependent Ulcerative Colitis: Induction and Maintenance of Clinical and Endoscopic Remission
- Status
- UNKNOWN
- Phase
- PHASE4
Correlation of Soluble Suppression of Tumorigenicity 2 (ST2) With Golimumab (MK-8259) Response in Participants With Ulcerative Colitis (UC) (MK-8529-022).
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Intravenous Golimumab in Pediatric Participants With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With Golimumab
- Status
- UNKNOWN
- Phase
- PHASE4
A Study of Golimumab in Participants With Active Ankylosing Spondylitis
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Golimumab in Participants With Active Psoriatic Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
Golimumab Utilization and Impact on Ulcerative Colitis (MK-8259-032)
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy of Golimumab in Combination With Methotrexate (MTX) Versus MTX Monotherapy, in Improving Dactylitis, in MTX naïve Psoriatic Arthritis Patients
- Status
- COMPLETED
- Phase
- PHASE3